SYED JAFFRI: Open Payments
NPI 1053369199 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,033 in 53 payments from 14 companies in 2025. Trend: 2023 $1,037 · 2024 $1,062 · 2025 $2,033
Food & beverage: $2,033
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $521 |
| Neurocrine BioSciences, Inc. | 11 | $403 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $319 |
| Teva Pharmaceuticals USA, Inc. | 3 | $182 |
| E.R. Squibb & Sons, L.L.C. | 2 | $151 |
| Janssen Scientific Affairs, LLC | 1 | $131 |
| Axsome Therapeutics, Inc. | 3 | $89 |
| Lundbeck LLC | 3 | $73 |
| ABBVIE INC. | 2 | $37 |
| Alkermes, Inc. | 1 | $31 |
Products named: FANAPT, INGREZZA, CAPLYTA, AUSTEDO XR, COBENFY, INVEGA SUSTENNA, REXULTI, Auvelity.
Industry payments across NY — which companies pay providers there.
